Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ESZOPICLONE vs ETESEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ESZOPICLONE vs ETESEVIMAB: Safety Overview

Metric ESZOPICLONE ETESEVIMAB
Total FAERS Reports 2,437 1,188
Deaths Reported 447 67
Death Rate 18.3% 5.6%
Hospitalizations 448 374
Average Patient Age 57.5 yrs 54.0 yrs
% Female Patients 65.5% 61.7%
FDA Approval Date Apr 15, 2014 N/A
Manufacturer Bryant Ranch Prepack N/A
Route ORAL N/A
Marketing Status Prescription N/A